NephroGenex, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2015-11-13: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2015-11-03; Total offering amount $28,500,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2015-11-13 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2015-11-03 | $28,500,000 | $5,500,000 | $23,000,000 | 14 |